secwatch.observer — SEC 8-K summary
======================================

Issuer:     Voyager Therapeutics, Inc. (VYGR)
CIK:        0001640266
Form:       8-K
Filed at:   2024-01-08T23:59:59+00:00
Accession:  0001104659-24-002271
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Voyager Therapeutics prices $100M public offering; closes $20M Novartis private placement
--------------------------------------------------------------------------------

- Public offering of 7,777,778 shares at $9.00/share and 3,333,333 pre-funded warrants at $8.999, gross proceeds ~$100M.
- Underwriters have 30-day option to purchase up to 1,666,665 additional shares at $9.00/share.
- Net proceeds estimated ~$93.5M (up to ~$107.6M if option exercised) to fund AD and ALS programs and working capital.
- Novartis private placement closed Jan 3, 2024: 2,145,002 shares at $9.324/share for ~$20M.
- Company expects cash runway into 2027 using existing cash, collaboration reimbursements, and Novartis upfront.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1640266/000110465924002271/0001104659-24-002271-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1640266/000110465924002271/tm242314d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-002271

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer